APPLICATIONS PUBLISHED 8 DECEMBER 2004
Published: 1-Sep-2005
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Treatment of immunological disorders using anti-CD30 antibodies
Seattle Genetics 1482972*
Methods of modulating CD200 receptors
Schering 1482973*
Electroporation methods for introducing bioactive agents into cells
Zycos 1492974*
Prevention of tissue adhesion
Vlaams Interuniversitair Instituut voor Biotechnologische; Thromb-X; KU Leuven Research & Development 1492974*
A preparation and method for weight reduction
Remedal 1492975*
Combination therapies for treating methylthioadenosine phosphorylase deficient cells
Pfizer 1482976*
Pharmaceutical compsns comprising osteoclastogenesis inhibitory factor
Sankyo 1482977*
Enhanced feeding and growth rates of aquatic animals fed an astaxanthin product derived from marigold extract
Prodemex 1482979*
Prostaglandin compsn for the treatment for erectile dysfunction
Nexmed 1482980*
Avdin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy
Sigma-Tau Industrie Farmaceutische Riunite 1482981*
Conjugates of the C domain of human gelatinase A and polyethylene glycol, methods of purification and uses thereof
F Hoffmann-La Roche 1482982*
Non-myeloablative tolerogenic treatment with tyrphostins
Yissum Research Development Company of the Hebrew University of Jerusalem 1482983*
Surrogate antibodies and methods of preparation and use thereof
Syntherica 1482984*
Tecnetium-dipyridine complexes, and methods of use thereof
Biostream 1482985*
Method for determining effect of a clostridial toxin upon a muscle
Allergan 1482986*
Multivalent constructs for therapeutic and diagnostic applications
Bracco International; Dyax Corp 1482987*
Method of radio-labelling biomolecules
Vistatec York 1482988*
Inactivation of microbes in biological fluids
Purepulse Technologies 1482989*
Improved method for the production of 4-(6-bromohexyloyl) butyl-benzene
Boehringer Ingelheim Pharma 1483226*
The purification of 2-methoxy-5-trifluoronethoxybenzaldehyde
Pfizer Products 1483227*
NK1 antagonists
Schering 1483228*
Resolution of chiral compounds using aminocyclopentadienyl ruthenium catalysts
Postech Foundation 1483229*
Method for producing ethyldimethylamine and triethylamine
BASF 1483230*
Novel cinnamate salts, method for production and use thereof as medicaments
Boehringer Ingelheim 1483231*
Salts of nateglinide
Novartis 1483232*
Substituted tetrahydroisoquinoline compounds, methods of making, and their use
The University of Tennessee Research Corporation 1483233*
Process for making 5-formylvaleronitrile using reactivated catalyst
Invista Technologies 1483234*
Process for preparation of isocyanates
BASF 1483235*
Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
Fujisawa Pharmaceutical 1483236*
Tropane compounds
President and Fellows of Harvard College' Organix 1483237*
Method for the simultaneous production of tetrahydrofurans and pyrrolidones
BASF 1483238*
Indole-amide derivatives and their use as glycogen phosphorylate inhibitors
AstraZeneca 1483239*
Indolamide derivatives which possess glycogen phosphrylase inhibitory activity
AstraZeneca 1483240*
Cyclic derivatives as modulators of chemokine receptor activity
Bristol-Myers Squibb 1483241*
Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
Merck Patent 1483242*
Preparation of N1-(2-pyridyl)-1,2-propanediamine sulphamic acid and its use in the synthesis of biologically active piperazines
Wyeth 1483243*
Cyclic N-substituted alpha iminocarboxylic acids for selectively inhibiting collagenase
Aventis Pharma 1483244*
5-substituted-alkylaminopyrazole derivatives as pesticides
Bayer CropScience 1483245*
5-substituted-alkylaminopyrazole derivatives as pesticides
Bayer CropScience 1483246*
Aryl substituted pyrimidines and the use thereof
Euro-Celtique 1483247*
Halobenzyl substituted phenylaceto esters and amides and use thereof for prevention of harmful organisms
Bayer CropScience 1483248*
C3-cyano epithilone derivatives
Bristol-Myers Squibb 1483251*
An antimicrobial agent
Griffith University; Monash University 1483253*
Resistance-repellant retrovirus protease inhibitors
Sequoia Pharmaceuticals 1483254*
Process for synthesising chiral N-aryl piperazines
Wyeth 1483256*
Process for making chiral 1,4-disubstituted piperazines
Wyeth 1483256*
Quinazoline compounds useful in therapy
Pfizer 1483257*
Benzimidazole derivatives for the treatment of sexual dysfunction
Abbott Laboratories 1483258*
Pyrimidines as novel openers of potassium ion channels
Icagen 1483259*
CDK inhibiting 2-heteroaryl pyrimidine, the production thereof, and use thereof as a medicament
Schering 1483260*
Phthalimide carboxylic acid derivatives
Oxford GlycoSciences; Scopes, David 1483261*
Coumarines useful as biomarkers
Novartis 1483262*
Thiazolul ureas compounds for the treatment of cancer
Amgen 1483263*
1-allyl ergot alkaloid derivatives, method for producing the same and the use thereof for preventing and treating migraine
NeuroBiotec 1483264*
Purine derivatives as kinase inhibitors
Eli Lilly 1483265*
Spiro compounds with NPY antagonist activity
Banyu Pharmaceutical 1483266*
Microtubule stabilising compounds
The Board of Trustees of the University of Illinois 1483267*
Indolyl-urea derivatives of thienopyriodines useful as antgiogenic agents
Pfizer 1483268*
Racemisation and enantiomer separation of clopidogrel
Teva Pharmaceutical Industries 1483269*
Heterocyclic amide derivatives having glycogen phosphorylase inhibitory activity
AstraZeneca 1483271*
Urea carbamate derivatives of crown ethers and silicon useful for the preparation of supports for chromatographic separation of metal cations and organic molecules comprising an amino function
Commisariat à l'Energie Atomique 1483272*
Aminocyclopentadienyl ruthenium complexes and preparation thereof
Postech Foundation 1483275*
Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
Sympore 1483277*
Processes for the synthesis of 5'-deoxy-5'-chloroadenosine and 5'-deoxy-5'-methylthioadenosine
Pfizer 1483279*
Fluorescent nitrogenous base and nucleosides incorporating same
Glen Research Corp 1483280*
Methods for producing interfering RNA molecules in mammalian cells and therapeutic uses for such molecules
City of Hope 1483281*
Ribozymes with broad TRNA aminocyclase activity
The Research Foundation of State University of New York 1483282*
Modulation of protein methylation and phosphoprotein phosphate
Signum Biosciences 1483283*
Selective dipeptide inhibitors of kallikrein
Ferring 1483284*
Inhibitors of the blood-clotting factor XA, production thereof and use of the same
Curacyte 1483285*
A process for the production of ramoplanin-like amide derivatives
Vicuron Pharmaceuticals 1483286*
An infectious bursal disease virus variant
Akzo Nobel 1483287*
HBM variants that modulate beno mass and lipid levels
Genome Therapeutics; Wyeth 1483288*
Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
Gene Signal 1483289*
Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments
Canbas 1483290*
Common protein surface shapes and uses therefor
The University of Queensland 1483291*
Monoclonal antibodies that are cross-reactive against bacterial collagen binding proteins
Università Degli Studi Di Pavia 1483292*
Use of an active substance that binds to CD28 for producing a pharmaceutical compsn
TeGenero 1483293*
Internalising anti-CD74 antibodies and methods of use
Immunomedics 1483294*
RS7 antibodies
Immunomedics 1483295*
Specific AB1'-antibodies against tumour-associated antigen CA 125
Cellcontrol Biomedical Laboratories 1483296*
Antibodies derived from anti ED-B-L19 and targeting tumour vascularisation
Philogen; Schering 1483297*
Oligomeric molecules and uses thereof
The Trustees of the University of Pennsylvania; Universite de Montreal 1483397*
Method of producing riboflavin
BASF 1483398*
Measurement of biosynthesis and breakdown rates of biological molecules that are inaccessible or not easily accessible to direct sampling, non-invasively, by label incorporation into metabolic derivatives and catabolitic products
The Regents of the University of California 1483399*
Use of the ACXL receptor for diagnosis and treatment of renal disease
Quark Biotech 1483400*
Method for selecting drug sensitivity-determining factors and method for predicting drug sensitivity using the selected factors
F Hoffmann-La Roche 1483401*
